Rethinking ovarian cancer: recommendations for improving outcomesSebastian Vaughan, Frances R. Balkwill, Euan A. Stronach et al.|Nature reviews. Cancer|2011Cited by 1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D.L. Bowtell, Frances R. Balkwill, Steffen Böhm et al.|Nature reviews. Cancer|2015Cited by 1.4k
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screensFiona M. Behan, Mathew J. Garnett, Francesco Iorio et al.|Nature|2019Cited by 1.4k
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian CancerEuan A. Stronach, Hani Gabra|Cancer Research|2011Cited by 179
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targetingFrancesco Iorio, Mathew J. Garnett, Fiona M. Behan et al.|BMC Genomics|2018Cited by 144